Title: Different Effects of Volatile and Nonvolatile Anesthetic Agents on Long-Term Survival in an Experimental Model of Hemorrhagic Shock
Date: April 15, 2020
Hemorrhagic shock is a major cause of mortality in soldiers and civilians undergoing trauma. In this study from the Cardiovascular Group at HMRI, Dr. Dai et al explored the concept that a cardioprotective volatile anesthetic agent, previously shown to reduce the size of experimental heart attacks, was superior to standard IV anesthetic in reducing mortality in an experimental model of hemorrhagic shock. This finding has important clinical implications for those undergoing surgery for trauma and experiencing hemorrhagic shock.